The tumor was confirmed to be an intermediate-grade MEC and was immunohistochemically positive for estrogen receptor (ER; Fig. 7D), p53, and Ki-67 and negative for progesterone receptor and human epidermal growth factor receptor 2. The gene discussed is ERBB2; the disease is mucoepidermoid carcinoma.